Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial

Tanzina Haque, Gwen M Wilkie, Marie M Jones, Craig D Higgins, Gillian Urquhart, Phoebe Wingate, David Burns, Karen McAulay, Marc Turner, Christopher Bellamy, Peter L Amlot, Deirdre Kelly, Alastair MacGilchrist, Maher K Gandhi, Anthony J Swerdlow, Dorothy H Crawford

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds